APA citiranje

Taher, A., Elalfy, M. S., Al Zir, K., Daar, S., Al Jefri, A., Habr, D., . . . El-Beshlawy, A. (2011). Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia. Blackwell Publishing Ltd.

Citação norma Chicago

Taher, Ali, et al. Importance of Optimal Dosing ≥30 Mg/kg/d During Deferasirox Treatment: 2.7-yr Follow-up From the ESCALATOR Study in Patients With β-thalassaemia. Blackwell Publishing Ltd, 2011.

MLA citiranje

Taher, Ali, et al. Importance of Optimal Dosing ≥30 Mg/kg/d During Deferasirox Treatment: 2.7-yr Follow-up From the ESCALATOR Study in Patients With β-thalassaemia. Blackwell Publishing Ltd, 2011.